Stock Analysis

3 Growth Companies On Euronext Paris With 19% Insider Ownership

ENXTPA:LSS
Source: Shutterstock

Despite recent declines in global markets, including a 3.65% drop in France's CAC 40 Index, investors continue to seek opportunities within the Euronext Paris exchange. In this environment, growth companies with high insider ownership can be particularly attractive due to their potential for strong alignment between management and shareholder interests.

Top 10 Growth Companies With High Insider Ownership In France

NameInsider OwnershipEarnings Growth
Groupe OKwind Société anonyme (ENXTPA:ALOKW)24.8%36%
VusionGroup (ENXTPA:VU)13.4%25.7%
Adocia (ENXTPA:ADOC)11.9%63%
Icape Holding (ENXTPA:ALICA)30.2%27.3%
Arcure (ENXTPA:ALCUR)21.4%27.5%
La Française de l'Energie (ENXTPA:FDE)19.9%31.9%
STIF Société anonyme (ENXTPA:ALSTI)16.4%28.5%
Munic (ENXTPA:ALMUN)29.2%149.1%
MedinCell (ENXTPA:MEDCL)15.8%93.9%
OSE Immunotherapeutics (ENXTPA:OSE)25.6%5.9%

Click here to see the full list of 24 stocks from our Fast Growing Euronext Paris Companies With High Insider Ownership screener.

Let's review some notable picks from our screened stocks.

Lectra (ENXTPA:LSS)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Lectra SA offers industrial intelligence solutions for the fashion, automotive, and furniture markets across Northern Europe, Southern Europe, the Americas, and the Asia Pacific with a market cap of €1.04 billion.

Operations: The company's revenue segments are €172.65 million from the Americas and €118.54 million from the Asia-Pacific region.

Insider Ownership: 19.6%

Lectra is trading 49.1% below its estimated fair value, with analysts predicting a 26.2% price rise. Earnings are forecast to grow significantly at 29.3% annually over the next three years, outpacing the French market's growth rate of 12.3%. However, return on equity is expected to be low at 13.2%. Recent earnings reports show sales increased to €262.29 million from €239.55 million year-over-year, though net income decreased slightly from €14.47 million to €12.51 million.

ENXTPA:LSS Ownership Breakdown as at Sep 2024
ENXTPA:LSS Ownership Breakdown as at Sep 2024

MedinCell (ENXTPA:MEDCL)

Simply Wall St Growth Rating: ★★★★★☆

Overview: MedinCell S.A. is a pharmaceutical company in France that develops long-acting injectables across various therapeutic areas, with a market cap of €493.91 million.

Operations: MedinCell generates €11.95 million in revenue from its pharmaceuticals segment.

Insider Ownership: 15.8%

MedinCell is trading at 87.6% below its estimated fair value, with analysts predicting a 29.8% price rise. The company is forecast to become profitable in the next three years, with revenue expected to grow at 46.2% annually, outpacing the French market's growth rate of 5.7%. Recent strategic alliances include a collaboration with AbbVie for up to six therapeutic products and Teva's commercial launch of UZEDY based on MedinCell’s BEPO® technology.

ENXTPA:MEDCL Earnings and Revenue Growth as at Sep 2024
ENXTPA:MEDCL Earnings and Revenue Growth as at Sep 2024

VusionGroup (ENXTPA:VU)

Simply Wall St Growth Rating: ★★★★★★

Overview: VusionGroup S.A. provides digitalization solutions for commerce across Europe, Asia, and North America, with a market cap of approximately €2.20 billion.

Operations: Revenue from installing and maintaining electronic shelf labels is €801.96 million.

Insider Ownership: 13.4%

VusionGroup's recent partnership with Ace Hardware to deploy advanced digital shelf label (DSL) technology underscores its innovative edge and growth potential. The company's revenue is forecast to grow at 21.3% annually, significantly outpacing the French market. Earnings are expected to increase by 25.7% per year, reflecting robust financial health. Despite no recent insider trading activity, VusionGroup's high insider ownership aligns management interests with shareholders, bolstering investor confidence in its long-term prospects.

ENXTPA:VU Ownership Breakdown as at Sep 2024
ENXTPA:VU Ownership Breakdown as at Sep 2024

Next Steps

Curious About Other Options?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com